DE3602577A1 - 9,10-dihydrogenierte ergotalkaloide enthaltende pharmazeutische zusammensetzungen - Google Patents

9,10-dihydrogenierte ergotalkaloide enthaltende pharmazeutische zusammensetzungen

Info

Publication number
DE3602577A1
DE3602577A1 DE19863602577 DE3602577A DE3602577A1 DE 3602577 A1 DE3602577 A1 DE 3602577A1 DE 19863602577 DE19863602577 DE 19863602577 DE 3602577 A DE3602577 A DE 3602577A DE 3602577 A1 DE3602577 A1 DE 3602577A1
Authority
DE
Germany
Prior art keywords
composition according
dihydroergotamine
composition
swellable substance
alkaloid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE19863602577
Other languages
German (de)
English (en)
Inventor
Othmar Allschwil Züger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Sandoz Patent GmbH
Original Assignee
Sandoz AG
Sandoz Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858502889A external-priority patent/GB8502889D0/en
Priority claimed from GB858517604A external-priority patent/GB8517604D0/en
Application filed by Sandoz AG, Sandoz Patent GmbH filed Critical Sandoz AG
Publication of DE3602577A1 publication Critical patent/DE3602577A1/de
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE19863602577 1985-02-05 1986-01-29 9,10-dihydrogenierte ergotalkaloide enthaltende pharmazeutische zusammensetzungen Ceased DE3602577A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858502889A GB8502889D0 (en) 1985-02-05 1985-02-05 Co-dergocrine compositions
GB858517604A GB8517604D0 (en) 1985-07-12 1985-07-12 Dihydroergotamine compositions

Publications (1)

Publication Number Publication Date
DE3602577A1 true DE3602577A1 (de) 1986-08-28

Family

ID=26288767

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19863602577 Ceased DE3602577A1 (de) 1985-02-05 1986-01-29 9,10-dihydrogenierte ergotalkaloide enthaltende pharmazeutische zusammensetzungen

Country Status (24)

Country Link
JP (1) JPS61183225A (it)
KR (1) KR920010388B1 (it)
AU (1) AU597570B2 (it)
BE (1) BE904152A (it)
CA (1) CA1263087A (it)
CH (1) CH667592A5 (it)
CY (1) CY1604A (it)
DE (1) DE3602577A1 (it)
DK (1) DK167138B1 (it)
ES (1) ES8800040A1 (it)
FR (1) FR2576787B1 (it)
GB (1) GB2170407B (it)
GR (1) GR860310B (it)
HK (1) HK57191A (it)
HU (1) HU195729B (it)
IE (1) IE59293B1 (it)
IT (1) IT1191255B (it)
LU (1) LU86289A1 (it)
NL (1) NL8600161A (it)
NZ (1) NZ215020A (it)
PH (1) PH23384A (it)
PT (1) PT81954B (it)
SE (1) SE8600496L (it)
SG (1) SG56191G (it)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2610827B1 (fr) * 1987-02-18 1991-09-13 Pf Medicament Comprime de dihydroergotamine (d.h.e.) du type a matrice hydrophile et son procede de fabrication
YU47044B (sh) * 1987-03-11 1994-12-28 LEK TOVARNA FARMACEVTSKIH IN KEMIČNIH IZDELKOV n.sol.o. Postupak za dobijanje tableta sa produženim delovanjem na bazi hidroksipropil-metilceluloze velike molekularne mase
US7771746B2 (en) 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
RU2256454C2 (ru) * 1999-12-03 2005-07-20 Полишем С.А. Способы получения фармацевтических композиций алкалоидов спорыньи с пролонгированным действием, характеризующихся улучшенной биодоступностью, и содержащие указанные алкалоиды композиции
US20030153620A1 (en) 2000-05-12 2003-08-14 Meakin Timothy David Treating eczema and/or psoriasis
NZ504526A (en) * 2000-05-12 2003-05-30 Meracol Corp Ltd Treating herpes simplex symptoms using a mixture of cetyl myristate and cetyl palmitate
WO2001085163A1 (en) * 2000-05-12 2001-11-15 Meracol Corporation Limited Treating eczema and/or psoriasis
US6696491B2 (en) 2000-05-12 2004-02-24 Meracol Corporation Limited Treating irritable bowel syndrome or disease
WO2003026640A1 (en) * 2001-09-28 2003-04-03 Meracol Corporation Limited Treating food allergies and/or food intolerances
CN111297815B (zh) * 2020-04-29 2022-04-15 宝利化（南京）制药有限公司 一种甲磺酸二氢麦角碱缓释片及其制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2304354A1 (fr) * 1975-03-17 1976-10-15 Hoffmann La Roche Nouvelles compositions pharmaceutiques a activite retardee

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3147187A (en) * 1962-09-10 1964-09-01 Don Hall Lab Sustained release pharmaceutical
DE3124983A1 (de) * 1981-06-25 1983-01-20 Meditest Inst Fuer Medizinisch Arzneiformen zur oralen verabreichung
CH649300A5 (de) * 1981-08-07 1985-05-15 Sandoz Ag Ergopeptinderivate, ihre herstellung und verwendung.
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
DE3303616A1 (de) * 1982-02-12 1983-08-25 Sandoz-Patent-GmbH, 7850 Lörrach Mutterkornalkaloide, verfahren zu deren herstellung sowie diese verbindungen enthaltende pharmazeutische zubereitungen
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
JPS604120A (ja) * 1983-06-22 1985-01-10 Shionogi & Co Ltd 作用持続型ピナシジル製剤
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
GB8413795D0 (en) * 1984-05-30 1984-07-04 Sandoz Ltd Organic compounds

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2304354A1 (fr) * 1975-03-17 1976-10-15 Hoffmann La Roche Nouvelles compositions pharmaceutiques a activite retardee

Also Published As

Publication number Publication date
ES551635A0 (es) 1987-10-16
JPS61183225A (ja) 1986-08-15
NL8600161A (nl) 1986-09-01
DK52086A (da) 1986-08-06
CA1263087A (en) 1989-11-21
PH23384A (en) 1989-07-26
PT81954A (en) 1986-03-01
IT8647620A0 (it) 1986-02-05
SE8600496D0 (sv) 1986-02-04
SG56191G (en) 1991-08-23
KR860006265A (ko) 1986-09-09
HUT41984A (en) 1987-06-29
IE59293B1 (en) 1994-02-09
KR920010388B1 (ko) 1992-11-27
HK57191A (en) 1991-08-02
CY1604A (en) 1992-04-03
GB2170407A (en) 1986-08-06
FR2576787A1 (fr) 1986-08-08
NZ215020A (en) 1989-07-27
CH667592A5 (de) 1988-10-31
ES8800040A1 (es) 1987-10-16
GR860310B (en) 1986-05-27
IT1191255B (it) 1988-02-24
LU86289A1 (fr) 1986-09-02
FR2576787B1 (fr) 1990-01-12
IE860291L (en) 1986-08-05
DK167138B1 (da) 1993-09-06
BE904152A (fr) 1986-08-04
GB2170407B (en) 1988-10-26
DK52086D0 (da) 1986-02-03
SE8600496L (sv) 1986-08-06
AU597570B2 (en) 1990-06-07
AU5294286A (en) 1986-08-14
GB8602602D0 (en) 1986-03-12
PT81954B (pt) 1988-07-01
HU195729B (en) 1988-07-28

Similar Documents

Publication Publication Date Title
DE3915347C2 (de) Harzadsorbate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
EP0265848B1 (de) Arzneizubereitungen zur oralen Verabreichung, die als Einzeldosis 10 bis 240 mg Dihydropyridin enthalten
DE69821553T2 (de) Granulatzubereitung enthaltend Simethicon und granuliertes wasserfreies Calciumphosphat
DE69802543T3 (de) Verbesserte multipartikel-tablette mit schnellauflösbarkeit
DE3520184C2 (de) Neue galenische Retardform
DE2224534B2 (de) Pharmazeutisches praeparat mit langsamer wirkstoffabgabe
DE3719818C2 (de) Pharmazeutische Zusammensetzung
DE69815856T2 (de) Cefadroxilmonohydrat tablettenformulierung
DE69814850T2 (de) Paracetamol enthaltende schlickbare tablette
EP1509207B1 (de) Pharmazeutische zusammensetzung, enthaltend oxcarbazepin mit kontrollierter wirkstofffreisetzung
DE3602577A1 (de) 9,10-dihydrogenierte ergotalkaloide enthaltende pharmazeutische zusammensetzungen
EP1140082A1 (de) Kombination von cerivastatin und fibraten
EP0205865B1 (de) Pharmazeutische Präparate mit antihypertensiver und kardioprotektiver Wirkung
EP0641200B1 (de) 2-arylpropionsäure-zubereitungen und verfahren zu ihrer herstellung
US5069911A (en) Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions
DE3505743C2 (de) Bromocriptin enthaltende Zusammensetzungen
EP0315197B1 (de) Oral anzuwendende Arzneiform zur einmal täglichen Behandlung der Hypertonie mit Diltiazemhydrochlorid
DD249186A1 (de) Herstellungsverfahren einer neuen glibenclamid-arzneiform mit hoher bioverfuegbarkeit
AT388101B (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur oralen verabreichung mit kontrollierter wirkstofffreisetzung
AT402257B (de) Verfahren zur herstellung von pharmazeutischen zusammensetzungen mit kontrollierter freisetzung eines 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro- 2,6-dimethyl-3,5-pyridindicarboxylatester- wirkstoffes
DE3419130A1 (de) Nifedipinkombinationspraeparate und verfahren zu ihrer herstellung
DE2621906C2 (it)
HU225779B1 (en) Pharmaceutical composition containing paracetamol and drotaverine and process for producing it
DE2532180C2 (de) Verwendung von Etozolin bei der Bekämpfung der Hypertonie
DE2456172C3 (de) Arzneimittel bei rheumatischen Erkrankungen

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8131 Rejection